Further research is needed to understand how these medications may influence mental health outcomes across different patient populations
Comparison of oxidative stress, lipid peroxidation and inflammatory markers between rheumatoid arthritis and ankylosing spondylitis patients
Tirzepatide additionally activates the GIP receptor a dual mechanism that produces superior weight loss outcomes in head-to-head trials
GLP-1
With a focus on transparency, quality, and science-backed supplements, we aim to empower individuals to make informed choices for their health and well-being
GLP-1-based therapies and resmetirom operate through distinct and potentially complementary mechanisms: while resmetirom exerts direct hepatic effects by activating THR- to enhance mitochondrial function, reduce hepatic lipogenesis, and promote lipid oxidation specifically in hepatocytes, GLP-1 RAs and multi-agonists address the upstream metabolic drivers of MASLD including insulin resistance, obesity, and systemic inflammation